|
Gimeno L, Gonzalez-Lozano I, Soto-Ramirez MF, Martinez-Sanchez MV, Lopez-Cubillana P, Fuster JL, Martinez-Garcia J, Martinez-Escribano J, Campillo JA, Pons-Fuster E, Ferri B, Lopez-Abad A, Muro M, Minguela A. CD8+ T lymphocytes are sensitive to NKG2A/HLA-E licensing interaction: role in the survival of cancer patients. Oncoimmunology. 2021 Oct 14;10(1):1986943. doi: 10.1080/2162402X.2021.1986943. eCollection 2021. PubMed PMID: 34676148; PubMed Central PMCID: PMC8525952.
AÑO: 2021; IF: 7.723
|
34676148
|
Minguela A, Vasco-Mogorron MA, Campillo JA, Cabanas V, Remigia MJ, Berenguer M, Garcia-Garay MC, Blanquer M, Cava C, Galian JA, Gimeno L, Soto-Ramirez MF, Martinez-Hernandez MD, de la Rubia J, Teruel AI, Muro M, Periago A. Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment. Am J Cancer Res. 2021 Sep 15;11(9):4438-4454. eCollection 2021. PubMed PMID: 34659897; PubMed Central PMCID: PMC8493371.
AÑO: 2021; IF: 5.942
|
|
Bernal E, Martinez M, Campillo JA, Puche G, Baguena C, Tomas C, Jimeno A, Alcaraz MJ, Alcaraz A, Munoz A, Oliver E, de la Torre A, Marin I, Cano A, Minguela A. Moderate to Intense Physical Activity Is Associated With Improved Clinical, CD4/CD8 Ratio, and Immune Activation Status in HIV-Infected Patients on ART. Open Forum Infect Dis. 2021 Dec 28;9(3):ofab654. doi: 10.1093/ofid/ofab654. eCollection 2022 Mar. Erratum In: Open Forum Infect Dis. 2022 Jul 13;9(7):ofac334. PubMed PMID: 35146043; PubMed Central PMCID: PMC8826224.
AÑO: 2022; IF: 4.2
|
|
Legaz I, Bolarin JM, Campillo JA, Moya-Quiles MR, Miras M, Muro M, Minguela A, Alvarez-Lopez MR. Killer Cell Immunoglobulin-like Receptors (KIR) and Human Leucocyte Antigen C (HLA-C) Increase the Risk of Long-Term Chronic Liver Graft Rejection. Int J Mol Sci. 2022 Oct 12;23(20):12155. doi: 10.3390/ijms232012155. PubMed PMID: 36293011; PubMed Central PMCID: PMC9603177.
AÑO: 2022; IF: 5.6
|
|
Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Cortes MB, Llinares ME, Jimenez I, Plaza M, Martinez Banaclocha H, Galian JA, Blanquer Blanquer M, Martinez Sanchez MV, Muro M, Minguela A. Measurable residual disease study through three different methods can anticipate relapse and guide early interventions in childhood acute lymphoblastic leukemia. Clin Transl Oncol. 2024 Jan;26(1):278-287. doi: 10.1007/s12094-023-03251-0. Epub 2023 Jun 27. PubMed PMID: 37368200.
AÑO: 2024; IF: 2.5
|